Unibio Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 151

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $758K

  • Investors
  • 7

Unibio General Information

Description

Provider of a bioindustrial platform intended to produce sustainable protein at an industrial scale and address global food security challenges. The company offers a patented Vertical Loop Bioreactor that converts methane into protein through efficient, modular, and climate-independent fermentation, enabling food producers and agribusinesses to reduce environmental impact, conserve resources, and ensure a resilient and scalable food supply.

Contact Information

Website
www.unibio.dk
Formerly Known As
Unibio Holding A/S
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Langebjerg 1
  • 4000 Roskilde
  • Denmark
+45 63
Primary Industry
Biotechnology
Other Industries
Other Consumer Non-Durables
Other Agriculture
Vertical(s)
Corporate Office
  • Langebjerg 1
  • 4000 Roskilde
  • Denmark
+45 63

Unibio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Unibio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC 01-Jun-2024 $758K Completed Generating Revenue
13. Later Stage VC 05-Jul-2023 Completed Generating Revenue
12. Later Stage VC 23-Dec-2022 Completed Generating Revenue
11. Debt - General 01-Jun-2021 Completed Generating Revenue
10. Later Stage VC 23-Dec-2019 Completed Generating Revenue
9. Corporate 04-Dec-2019 Completed Generating Revenue
8. Grant 01-Jan-2016 Completed Generating Revenue
7. Later Stage VC 10-Jun-2015 Completed Generating Revenue
6. Later Stage VC 09-Oct-2014 $793K $3.01M Completed Generating Revenue
5. Grant 01-Jan-2014 $2.21M Completed Generating Revenue
To view Unibio’s complete valuation and funding history, request access »

Unibio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 82,600 $3.3 $3.3 1x $3.3 1.22%
Ordinary 55,500 $1.27 $1.27 1x $1.27 0.82%
To view Unibio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Unibio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of a bioindustrial platform intended to produce sustainable protein at an industrial scale and address global f
Biotechnology
Roskilde, Denmark
151 As of 2026

San Mateo, CA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Unibio Competitors (3)

One of Unibio’s 3 competitors is Calysta, a Venture Capital-Backed company based in San Mateo, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Calysta Venture Capital-Backed San Mateo, CA
Knip (Commercial Products) Venture Capital-Backed Boston, MA
Arbiom Venture Capital-Backed Paris, France
You’re viewing 3 of 3 competitors. Get the full list »

Unibio Patents

Unibio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026229544-A1 A fermentor and method of performing a fermentation process Pending 30-Apr-2025
WO-2026229545-A1 A fermentor and method of performing a fermentation process Pending 30-Apr-2025
WO-2025116037-A1 Modified p4hb Inactive 01-Dec-2023
AU-2024373981-A1 A fermentor and method of performing a fermentation process Pending 31-Oct-2023
EP-4802043-A1 A fermentor and method of performing a fermentation process Pending 31-Oct-2023 C12M29/18
To view Unibio’s complete patent history, request access »

Unibio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Unibio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Double Bioventures Venture Capital Minority
ICP Group (Denmark) Venture Capital Minority
Saudi Industrial Investment Group Holding Company Minority
Wealth Club Corporation Minority
Mitsubishi Corporation Minority
You’re viewing 5 of 7 investors. Get the full list »

Unibio Investments (5)

Unibio’s most recent deal was a Joint Venture with Single-Cell Protein Plant (Saudi Industrial Investment Group / Unibio International) for . The deal was made on 16-Mar-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Single-Cell Protein Plant (Saudi Industrial Investment Group / Unibio International) 16-Mar-2026 Joint Venture Food Products
Arrow Therapeutics 01-Dec-2003 Early Stage VC Drug Discovery
Inpharmatica 03-Jul-2001 Early Stage VC Discovery Tools (Healthcare)
Arrow Therapeutics 06-Jul-2000 Early Stage VC Drug Discovery
Arrow Therapeutics 01-Jan-1999 Seed Round Drug Discovery
To view Unibio’s complete investments history, request access »

Unibio FAQs

  • When was Unibio founded?

    Unibio was founded in 2001.

  • Where is Unibio headquartered?

    Unibio is headquartered in Roskilde, Denmark.

  • What is the size of Unibio?

    Unibio has 151 total employees.

  • What industry is Unibio in?

    Unibio’s primary industry is Biotechnology.

  • Is Unibio a private or public company?

    Unibio is a Private company.

  • What is Unibio’s current revenue?

    The current revenue for Unibio is .

  • How much funding has Unibio raised over time?

    Unibio has raised $123M.

  • Who are Unibio’s investors?

    Double Bioventures, ICP Group (Denmark), Saudi Industrial Investment Group, Wealth Club, and Mitsubishi are 5 of 7 investors who have invested in Unibio.

  • Who are Unibio’s competitors?

    Calysta, Knip (Commercial Products), and Arbiom are competitors of Unibio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process